Myocardial Infarction Therapeutics - Global Market Outlook (2015-2022)

March 2016 | 134 pages | ID: M8593C51CB3EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Myocardial Infarction Therapeutics Market is estimated at $XX million in 2015 and is projected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Growing research application, rising demand in increasing incidence of coronary artery disease and changes in lifestyle are some of the key factors driving the market growth. Increasing number of smokers, increasing incidence of obesity and blood pressures, lack of exercise are some of the factors favouring the market growth. However, saturation in R&D would be the major restraint hampering the market.

Analgesics and antiplatelet agents segments are expected to hold more share in this market as these agents are used for initial treatment of an acute myocardial infarction. North America is the fastest growing market in global myocardial infarction therapeutic market due to rise in aging population and prevalence of co-morbidities.

Some of the key players in the market include Anthera Pharmaceuticals, AstraZeneca, Apotex Inc., Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Capricor Inc., Daiichi Sankyo Company Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck and Co. Inc., Mylan N.V., Novartis N.V., Par Pharmaceutical Companies, Inc., Pfizer Inc., Portola Pharmaceuticals Inc., Sandoz, Sanofi and The Medicines Company.

Products Covered:

• Analgesics
• Antiplatelet agents
• Vasodilators
• Thrombolytics and anti-thrombotic agents
• Glycoprotein IIb/IIIa inhibitors
• Β adrenergic blockers
• Angiotensin receptor antagonists
• Angiotensin converting enzyme inhibitors
• Antithrombotic agents

Distribution Channel Covered:

• Hospitals
• Hospital Pharmacies
• Drug Stores
• Online drug stores

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL MYOCARDIAL INFARCTION THERAPEUTICS MARKET, BY PRODUCT TYPE

5.1 Introduction
5.2 Analgesics
5.3 Antiplatelet agents
5.4 Vasodilators
5.5 Thrombolytics and anti-thrombotic agents
5.6 Glycoprotein IIb/IIIa inhibitors
5.7 Β adrenergic blockers
5.8 Angiotensin receptor antagonists
5.9 Angiotensin converting enzyme inhibitors
5.10 Antithrombotic agents

6 GLOBAL MYOCARDIAL INFARCTION THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

6.1 Introduction
6.2 Hospitals
6.3 Hospital Pharmacies
6.4 Drug Stores
6.5 Online drug stores

7 GLOBAL MYOCARDIAL INFARCTION THERAPEUTICS MARKET, BY GEOGRAPHY

7.1 North America
  7.1.1 US
  7.1.2 Canada
  7.1.3 Mexico
7.2 Europe
  7.2.1 Germany
  7.2.2 France
  7.2.3 Italy
  7.2.4 UK
  7.2.5 Spain
  7.2.6 Rest of Europe
7.3 Asia Pacific
  7.3.1 Japan
  7.3.2 China
  7.3.3 India
  7.3.4 Australia
  7.3.5 New Zealand
  7.3.6 Rest of Asia Pacific
7.4 Rest of the World
  7.4.1 Middle East
  7.4.2 Brazil
  7.4.3 Argentina
  7.4.4 South Africa
  7.4.5 Egypt

8 KEY DEVELOPMENTS

8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 COMPANY PROFILING

9.1 Anthera Pharmaceuticals
9.2 AstraZeneca, Apotex Inc.
9.3 Bayer AG
9.4 Boehringer Ingelheim GmbH
9.5 Bristol-Myers Squibb Company
9.6 Capricor Inc.
9.7 Daiichi Sankyo Company Limited
9.8 GlaxoSmithKline Plc
9.9 Johnson & Johnson
9.10 Merck and Co. Inc.
9.11 Mylan N.V.
9.12 Novartis N.V.
9.13 Par Pharmaceutical Companies, Inc.
9.14 Pfizer Inc.
9.15 Portola Pharmaceuticals Inc.
9.16 Sandoz
9.17 Sanofi
9.18 The Medicines Company

List Of Tables

LIST OF TABLES

Global Myocardial Infarction Therapeutics Market Outlook, By Region (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Product (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Analgesics (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Hospitals (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (201-2022) ($MN)
Global Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Product (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Analgesics (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Hospitals (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (201-2022) ($MN)
North America Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Product (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Analgesics (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Hospitals (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (201-2022) ($MN)
Europe Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Product (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Analgesics (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Hospitals (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (201-2022) ($MN)
Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Product (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Analgesics (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Hospitals (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (201-2022) ($MN)
Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (201-2022) ($MN)